Influenzinum
Product Images NDC 0220-2719

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Influenzinum (NDC 0220-2719). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boiron, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Influenzinum 2021 2022 9c Udt)

Label (Influenzinum 2021 2022 9c Udt)
Partial drug facts label for Influenziunum by Boiron, showing the active ingredient Influenziunum 9C, usage information, warnings, directions, other information, and inactive ingredients. The label indicates the product is a homeopathic medicine made in France and distributed by Boiron Inc. Contact information is partially visible.*
FDA Label Image

Label (Influenzinum 2021 2022 9c)

Label (Influenzinum 2021 2022 9c)
Drug Facts panel for Influenzeinm 9C homeopathic medicine by Boiron. The label includes active ingredient amount per pellet, usage directions for adults and children, warnings for persistent symptoms and pregnancy, and inactive ingredients lactose and sucrose. It also provides contact information for Boiron USA and instructions on how to dispense pellets from the tube.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.